The bad news is that currently available meds are only mildly effective, and by "effective" I mean effective in prolonging disease progression. The good news

The bad news is that currently available meds are only mildly effective, and by "effective" I mean effective in prolonging disease progression. The good news is that there is a ton of research being done (I work in this area). Some people are a bit squeamish about getting involved in clinical trials, but if I were in your position, you can bet I would enroll my parent in a trial. The best resource for finding what's enrolling in your area is www.clinicaltrials.gov. Elan is about to start a phase III trial on their Alzheimer's vaccine, Bapineuzumab, and it has generated quite a bit of buzz. http://www.reuters.com/article/healthNews/idUSL2153046720070521?pageNumber=2&virtualBrandChannel=0&sp=true http://www.reuters.com/article/healthNews/idUSL2153046720070... As I said, I work in this area and obviously carry a bias. However, I did not see anyone else suggest the possibility of clinical trials, so I thought I should throw it out there to consider among the other options.